These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 18174692

  • 1. Potential new indications of topical calcineurin inhibitors.
    Luger T, Paul C.
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [Abstract] [Full Text] [Related]

  • 2. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT, Thaçi D, Luger T.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
    [Abstract] [Full Text] [Related]

  • 3. Innovative use of topical calcineurin inhibitors.
    Lin AN.
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T, Kapp A, Spergel J.
    Dermatology; 2005 Jul; 211(2):174-87. PubMed ID: 16088174
    [Abstract] [Full Text] [Related]

  • 5. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 6. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 7. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U, Hansel G, Koch A, Abdel-Naser MB.
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [Abstract] [Full Text] [Related]

  • 8. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V, Griffiths CE.
    Dermatol Ther; 2007 Oct; 20(4):239-50. PubMed ID: 17970889
    [Abstract] [Full Text] [Related]

  • 9. The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
    Wollina U, Hansel G.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):1-6. PubMed ID: 18005117
    [Abstract] [Full Text] [Related]

  • 10. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Jan; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 13. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
    Meurer M, Lubbe J, Kapp A, Schneider D.
    Dermatology; 2007 Dec; 215 Suppl 1():18-26. PubMed ID: 18174690
    [Abstract] [Full Text] [Related]

  • 14. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.
    Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
    [Abstract] [Full Text] [Related]

  • 15. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G, Sułowicz W, Paczek L.
    Przegl Lek; 2002 Dec; 59(11):907-11. PubMed ID: 12715720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135
    [Abstract] [Full Text] [Related]

  • 18. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I, Quan LT, Hsu S.
    Dermatol Online J; 2003 Aug 14; 9(3):13. PubMed ID: 12952760
    [Abstract] [Full Text] [Related]

  • 19. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
    Scheinfeld N.
    Dermatol Online J; 2004 Jul 15; 10(1):3. PubMed ID: 15347485
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC, Burgdorf WH, Wollenberg A.
    Curr Opin Investig Drugs; 2002 May 15; 3(5):708-12. PubMed ID: 12090543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.